FRANCIS SICARI: Open Payments
NPI 1073080768 · PORT JEFFERSON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,612 in 155 payments from 20 companies in 2025. Trend: 2023 $2,214 · 2024 $2,617 · 2025 $3,612
Food & beverage: $3,532Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $486 |
| Arcutis Biotherapeutics, Inc. | 9 | $392 |
| Amgen Inc. | 11 | $344 |
| ABBVIE INC. | 13 | $333 |
| UCB, Inc. | 13 | $316 |
| Novartis Pharmaceuticals Corporation | 15 | $293 |
| Galderma Laboratories, L.P. | 20 | $254 |
| Regeneron Healthcare Solutions, Inc. | 11 | $219 |
| Incyte Corporation | 10 | $209 |
| PFIZER INC. | 8 | $203 |
Products named: TREMFYA, Zoryve, Bimzelx, DUPIXENT, NEMLUVIO, OTEZLA, COSENTYX, OPZELURA.
Industry payments across NY — which companies pay providers there.
